Tirzepatide 60mg
$219.99
Tirzepatide is a dual GIP/GLP-1 receptor agonist widely studied in metabolic research contexts. Supplied as lyophilized powder, 60mg per vial. Third-party tested for identity and purity. For research use only.
18 in stock
Tirzepatide is a synthetic dual agonist peptide that simultaneously activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It represents a novel mechanism of incretin-based research, combining two distinct hormonal pathways in a single molecule.
Research Applications: As a dual incretin receptor agonist, tirzepatide is studied extensively in metabolic research. Clinical and preclinical investigations have examined its effects on glycemic control, body weight reduction, insulin sensitivity, and cardiovascular risk factors. Research has demonstrated significant reductions in HbA1c and body weight in diabetic models.
Key Research Areas:
- Type 2 diabetes and glycemic regulation
- Obesity and body composition research
- Cardiovascular metabolic risk factors
- Insulin sensitivity and beta-cell function
- Dual GIP/GLP-1 receptor pharmacology
For research purposes only. Not for human or veterinary use. Store lyophilized vials at -20°C. After reconstitution with BAC water, refrigerate and use within 4–6 weeks.
Every batch sold by Alpha Peptides US is independently tested by a certified third-party laboratory. The Certificate of Analysis (CoA) below confirms the identity, purity, and net content of this product.
Testing performed by Freedom Diagnostics Testing via LC-MS/MS under standard laboratory conditions. Results are specific to the tested batch and are intended for research purposes only.
View Certificate of Analysis (PDF)Research use only. Not intended for human or veterinary use, diagnostic, therapeutic, or clinical applications.
Reviews
There are no reviews yet.